REPL vs TROW
Replimune Group Inc (REPL) versus T. Rowe Price Group Inc (TROW) — a side-by-side from cached financials, not a winner call.
Replimune Group Inc (REPL) is a biotechnology company listed on NASDAQ.
T. Rowe Price Group Inc (TROW) is a asset management company listed on NASDAQ.
REPL does not have a complete income-statement cache yet.
Latest reported TROW revenue for 2024-12-31 was $7.09B. Net income was $2.14B. Revenue was up 9.8% from 2023-12-31 to 2024-12-31. TROW currently screens at market cap $23.17B and trailing P/E 11.6.
REPL currently screens at market cap $825.7M. TROW currently screens at market cap $23.17B and trailing P/E 11.6.
Not investment advice. Open the REPL and TROW stock pages for the full models.
Not investment advice.